| BeOne Medicines I GmbH - Tevimbra 100 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 68960 | | 01 | | Tevimbra 100 mg/10 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01FF09 | | Tislelizumab | | 11.04.2024 | | |
|
| Composition |
| tislelizumabum 100 mg, natrii citras dihydricus, acidum citricum monohydricum, histidini hydrochloridum monohydricum, histidinum, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 16 mg. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Tislelizumabum | 100mg / 10ml |
| | BAG: Active Agent | Dose |
|---|
| Tislelizumabum | 100 mg |
| | | | Inactive agents |
|---|
| Citric Acid Monohydrate | | Histidin Hydrochloride Monohydrate | | Histidine | | Natrii Citras Dihydricus | | Polysorbatum 20 | | Trehalosum Dihydricum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 1625.65 | 1784.40 | A | SL | Yes |
|